The Top 12 Cell Culture Dish Blogs of 2012
To cap off this year, I have compiled a list of our top 12 Cell Culture Dish blogs for 2012. I hope you enjoy a few that you may have … Continued
To cap off this year, I have compiled a list of our top 12 Cell Culture Dish blogs for 2012. I hope you enjoy a few that you may have … Continued
This week’s headlines include, possible Thimerosal ban threatens vaccinations for the world’s poor, market strategy options for start up biotech companies, stem cells studied as a possible treatment option for … Continued
This week’s headlines include, new drug approvals, best biotech CEO of 2012, whole genome sequencing and gene patents, focus on treatment for ALS, and pediatricians change their position on Thimerosal. … Continued
Corning Life Sciences ASCB December 17, 2012 Marshall Kosovsky, Ph.D., Technical Support Manager
This week’s headlines include, upcoming stem cell trial without embryo destruction, fiscal cliff could create problems for biotechs, Britain launches genome database, global pediatric market on the rise, and experimental … Continued
In a recent report issued by the Food and Drug Administration (FDA) “Fiscal Year 2012 Innovative Drug Approvals,” the agency highlighted 35 new drug approvals. This marks the second year … Continued
This week’s headlines include, flu season arrives early, new stem cell academic – industry partnership, FDA approvals increase this year, FDA ready to rethink antibiotic clinical requirements, application of stem … Continued
In recent months we have provided in depth coverage on new cell culture based vaccine technologies, media supplements and manufacturing equipment. Vaccine related topics continue to be highly searched at … Continued
This week’s headlines include, cell culture-based flu vaccine approved in U.S., 2012 biotech startups, FDA makes another stem cell related approval, new antibody shows promise as obesity treatment and 3-D … Continued
The ability of human embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs) to proliferate continuously and form derivatives of all three germ layers makes them attractive to researchers … Continued
Last week Fierce Vaccines posted an article on the top selling flu vaccines of 2012. Novartis’ Optiflu™ was number seven on the list with sales steadily increasing since approval by … Continued